The shareholders of Cellectis (ENXTPA:ALCLS) authorized a share repurchase program at its Combined General Shareholders' Meeting on June 14, 2013. Under the program, the company will repurchase its own shares.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.715 EUR | 0.00% | -1.09% | -1.77% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.77% | 211M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- ALCLS Stock
- News Cellectis S.A.
- Cellectis announces an Equity Buyback.